Zirsudh Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 31-12-2024
- Paid Up Capital ₹ 0.10 M
as on 31-12-2024
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Revenue -62.06%
(FY 2022)
- Profit -273.69%
(FY 2022)
- Ebitda -304.16%
(FY 2022)
- Net Worth -76.46%
(FY 2022)
- Total Assets 21.95%
(FY 2022)
About Zirsudh Life Sciences
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Narasimhamurthy Naveen and Ravindra Pavan serve as directors at the Company.
- CIN/LLPIN
U74999KA2020PTC132027
- Company No.
132027
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jan 2020
- Date of AGM
29 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Zirsudh Life Sciences Private Limited offer?
Zirsudh Life Sciences Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Organic Soap, Herbal Soaps.
Who are the key members and board of directors at Zirsudh Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narasimhamurthy Naveen  | Director | 28-Jan-2020 | Current |
| Ravindra Pavan | Director | 28-Jan-2020 | Current |
Financial Performance of Zirsudh Life Sciences.
Zirsudh Life Sciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 62.06% decrease. The company also saw a substantial fall in profitability, with a 273.69% decrease in profit. The company's net worth observed a substantial decline by a decrease of 76.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zirsudh Life Sciences?
Unlock access to Zirsudh Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zirsudh Life Sciences?
Unlock and access historical data on people associated with Zirsudh Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zirsudh Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zirsudh Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
